Thermo Fisher Scientific Inc (TMO) is Tesco Pension Investment Ltd’s 5th Largest Position

Tesco Pension Investment Ltd increased its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 3.2% during the second quarter, Holdings Channel reports. The fund owned 1,046,409 shares of the medical research company’s stock after buying an additional 32,486 shares during the period. Thermo Fisher Scientific makes up about 5.4% of Tesco Pension Investment Ltd’s portfolio, making the stock its 5th largest position. Tesco Pension Investment Ltd’s holdings in Thermo Fisher Scientific were worth $182,567,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in TMO. BlackRock Inc. boosted its position in Thermo Fisher Scientific by 2,692.1% in the first quarter. BlackRock Inc. now owns 22,988,885 shares of the medical research company’s stock valued at $3,531,095,000 after buying an additional 22,165,530 shares during the period. C WorldWide Group Holding A S boosted its position in Thermo Fisher Scientific by 997.1% in the first quarter. C WorldWide Group Holding A S now owns 1,950,049 shares of the medical research company’s stock valued at $299,527,000 after buying an additional 1,772,300 shares during the period. Veritas Asset Management LLP acquired a new position in Thermo Fisher Scientific during the first quarter valued at about $175,795,000. Vanguard Group Inc. boosted its position in Thermo Fisher Scientific by 2.7% in the first quarter. Vanguard Group Inc. now owns 25,971,301 shares of the medical research company’s stock valued at $3,989,193,000 after buying an additional 695,079 shares during the period. Finally, Renaissance Technologies LLC boosted its position in Thermo Fisher Scientific by 68.8% in the first quarter. Renaissance Technologies LLC now owns 1,373,044 shares of the medical research company’s stock valued at $210,900,000 after buying an additional 559,400 shares during the period. Hedge funds and other institutional investors own 87.05% of the company’s stock.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.40% during midday trading on Friday, reaching $175.97. The company had a trading volume of 1,326,913 shares. The firm’s 50 day moving average price is $176.80 and its 200-day moving average price is $163.47. The stock has a market capitalization of $68.63 billion, a price-to-earnings ratio of 30.66 and a beta of 1.06. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $182.87.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. Thermo Fisher Scientific’s quarterly revenue was up 10.2% on a year-over-year basis. During the same period last year, the business posted $2.03 EPS. Equities research analysts expect that Thermo Fisher Scientific Inc will post $9.24 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 annualized dividend and a yield of 0.34%. Thermo Fisher Scientific’s payout ratio is currently 10.45%.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece on another website, it was stolen and republished in violation of United States and international trademark and copyright law. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/07/29/thermo-fisher-scientific-inc-tmo-is-tesco-pension-investment-ltds-5th-largest-position.html.

Several equities analysts have recently issued reports on TMO shares. Leerink Swann set a $187.00 target price on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Thursday, April 27th. Barclays PLC set a $175.00 target price on Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Wednesday, April 26th. BTIG Research boosted their target price on Thermo Fisher Scientific from $180.00 to $190.00 and gave the company a “buy” rating in a research note on Friday, April 28th. Deutsche Bank AG boosted their target price on Thermo Fisher Scientific from $163.00 to $188.00 and gave the company a “buy” rating in a research note on Friday, April 28th. Finally, Jefferies Group LLC boosted their target price on Thermo Fisher Scientific from $160.00 to $175.00 and gave the company a “hold” rating in a research note on Friday, April 28th. One analyst has rated the stock with a hold rating, fifteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average target price of $188.69.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 20,000 shares of the firm’s stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $172.79, for a total transaction of $3,455,800.00. Following the transaction, the chief executive officer now directly owns 269,279 shares in the company, valued at approximately $46,528,718.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Daniel P. Shine sold 4,688 shares of the firm’s stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $171.88, for a total value of $805,773.44. Following the transaction, the insider now owns 29,200 shares in the company, valued at $5,018,896. The disclosure for this sale can be found here. Insiders have sold a total of 27,188 shares of company stock worth $4,702,223 over the last 90 days. 0.49% of the stock is currently owned by company insiders.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

six + thirteen =